The average one-year price target for NeoGenomics (NasdaqCM:NEO) has been revised to $12.44 / share. This is an increase of 21.45% from the prior estimate of $10.25 dated November 7, 2025. The price ...

$NEO insiders have traded $NEO stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales. Here’s a ...

A downtrend has been apparent in NeoGenomics (NEO) lately. While the stock has lost 6.6% over the past week, it could witness a trend reversal as a hammer chart pattern was formed in its last trading ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

Needham analysts said that a newly issued preliminary injunction preventing NeoGenomics (NASDAQ:NEO) from selling its RaDaR liquid biopsy test in the US “bodes poorly” for the company prevailing in ...

Neo Performance Materials Inc. reported its third-quarter 2025 earnings, significantly surpassing market expectations with an earnings per share (EPS) of $0.19, compared to the forecasted $0.099, ...